Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for noninvasive tests of carotid function, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS noninvasive carotid function testing is a niche but financially meaningful area for vascular surgery, neurology, and radiology practices. This modification updates the terms under which Medicare will cover these diagnostic studies. The policy does not carry a numbered policy code in the standard NCD or LCD format — it is identified by its title, "Noninvasive Tests of Carotid Function." No specific CPT or HCPCS codes are listed in the published policy data for this modification, which is itself a problem your billing team needs to address before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Noninvasive Tests of Carotid Function |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium — affects vascular, neurology, and radiology billing |
| Specialties Affected | Vascular Surgery, Neurology, Interventional Radiology, Cardiology |
| Key Action | Review your charge capture and documentation workflows for noninvasive carotid testing before May 15, 2026 |
CMS Noninvasive Carotid Function Coverage Criteria and Medical Necessity Requirements 2026
The CMS noninvasive carotid function coverage policy governs when Medicare will pay for diagnostic studies that assess blood flow, stenosis, and vascular function in the carotid arteries without surgical intervention. These tests include duplex ultrasound scanning, oculoplethysmography, and other noninvasive hemodynamic studies used to evaluate stroke risk and carotid artery disease.
The core of any CMS coverage policy in this space comes down to medical necessity. Medicare does not pay for carotid testing performed as a screening tool in asymptomatic, low-risk patients. Medical necessity requires a documented clinical indication — symptoms consistent with transient ischemic attack (TIA), stroke, or carotid bruits on examination, a documented history of carotid disease, or pre-operative or post-operative surveillance in patients who have undergone carotid endarterectomy or stenting.
This is the standard CMS has held to for years in this diagnostic category, and this modification reinforces it. If your physicians are ordering these tests without clear clinical documentation of the qualifying indication, your claims will not survive scrutiny. That is not a new risk — but a policy modification is CMS's way of signaling renewed attention to a billing area.
Whether this update also introduces any new prior authorization requirements at the Medicare Administrative Contractor level is something you need to confirm with your specific MAC before the effective date. CMS national policy sets the floor; your MAC can layer on additional requirements through a local coverage determination (LCD). Check your MAC's website for any companion LCD changes effective May 15, 2026, or shortly before.
The reimbursement question follows from coverage. If a test does not meet medical necessity under the updated coverage policy, Medicare will not pay — and you will not be able to bill the patient for it either, unless you have an Advance Beneficiary Notice (ABN) in place before the service. Get that ABN workflow right now, not after you get your first denial.
CMS Noninvasive Carotid Function Exclusions and Non-Covered Indications
CMS has historically drawn clear lines around what does not qualify as a covered noninvasive carotid study under Medicare billing guidelines.
Routine screening is not covered. A patient with no neurological symptoms, no known carotid disease, and no prior vascular intervention does not meet medical necessity. Ordering a carotid duplex because a patient is elderly or has hypertension is not enough. The documentation must show a symptom-driven or clinically justified reason tied to a specific diagnosis.
Repeat testing without clinical change is not covered. If a patient had a noninvasive carotid study six months ago and nothing in their clinical status has changed, ordering another study will not meet medical necessity. Your physicians need to document why repeat testing is warranted — new symptoms, progression of known disease, or a specific surveillance interval tied to a prior procedure.
Experimental or unproven modalities are also outside coverage. CMS has not broadly endorsed every new waveform analysis or computational hemodynamic assessment tool as a covered service. If your practice uses any technology that goes beyond standard duplex ultrasound or established plethysmographic methods, confirm coverage before billing.
The real issue here is documentation, not technology. Most claim denial problems in this category trace back to vague physician notes, missing symptom documentation, or orders that lack a specific ICD-10 diagnosis code tying the test to a covered indication.
Coverage Indications at a Glance
The published policy data for this modification does not include a coded indication list. The table below reflects the established CMS framework for this type of coverage policy, based on longstanding Medicare billing guidelines for noninvasive carotid studies.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Symptomatic carotid disease (TIA, stroke symptoms, carotid bruit) | Covered | ICD-10 codes for TIA, stroke, carotid stenosis — verify with your MAC | Strong medical necessity documentation required |
| Pre-op evaluation before carotid endarterectomy or stenting | Covered | Procedure-linked diagnosis codes | Document the planned procedure in the record |
| Post-op surveillance after carotid endarterectomy or stenting | Covered | Surveillance interval must be clinically justified | Frequency limits may apply under your MAC's LCD |
| Asymptomatic screening in low-risk patients | Not Covered | N/A | ABN required if patient requests and physician agrees to perform |
| Repeat testing without documented clinical change | Not Covered | N/A | Document new symptoms or progression if billing for repeat study |
| Unvalidated or experimental hemodynamic assessment tools | Not Covered | N/A | Confirm with your MAC before billing new technologies |
Note: This table reflects established CMS medical necessity principles. The published policy modification does not list specific CPT, HCPCS, or ICD-10 codes. Confirm code-level coverage with your MAC or compliance officer.
CMS Noninvasive Carotid Function Billing Guidelines and Action Items 2026
The absence of specific codes in the published policy data is not a green light. It means you have work to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's LCD for noninvasive carotid testing now. Your Medicare Administrative Contractor publishes local coverage determinations that specify which CPT codes are covered, which ICD-10 diagnosis codes support medical necessity, and whether prior authorization is required. This is your operational document. The CMS national policy sets the standard; the LCD tells you how to bill. |
| 2 | Audit your last 90 days of noninvasive carotid claims. Look at what CPT codes you are using, what diagnosis codes are attached, and whether the physician documentation actually supports the coded indication. Identify any patterns that look like they could draw a claim denial under the updated coverage policy. |
| 3 | Update your ABN workflow before May 15, 2026. Any patient who requests a noninvasive carotid study that does not clearly meet medical necessity criteria needs an ABN before the service. Your front-desk and clinical staff need to know when to trigger this process. |
| 4 | Review your ordering physician documentation templates. Vague orders like "carotid check" or "vascular screening" will not protect you on audit. Your templates should prompt the ordering physician to document specific symptoms, relevant history, and the clinical question the test is meant to answer. |
| 5 | Confirm your CPT code usage against current coding guidelines. The policy does not list specific codes — which means you need to verify that the codes your team uses for noninvasive carotid testing still map correctly to covered services under this updated policy. If you are unsure which CPT codes apply to your specific test mix, talk to your billing consultant before the effective date. |
| 6 | Check for any companion billing guideline updates from CMS or your MAC. Policy modifications at the national level often coincide with LCD updates or contractor guidance releases. Set up alerts through your MAC's listserv or through a policy tracking tool so you catch any follow-on changes. |
| 7 | Loop in your compliance officer if you bill high volumes of these studies. If noninvasive carotid testing represents significant revenue for your practice or facility, a policy modification is the right trigger for a formal compliance review. Your compliance officer should assess your documentation standards, ABN usage, and denial patterns against the updated coverage criteria. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Noninvasive Carotid Testing Under This Policy
The published policy data for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for a CMS national-level coverage policy update — code-level specificity typically lives in the MAC's LCD, not the national policy document.
Do not treat the absence of codes in this document as confirmation that your current codes are correct. It means you need to verify independently.
How to Find the Applicable Codes
Check your MAC's LCD for noninvasive carotid arterial studies. Major MACs — including Novitas, CGS, Palmetto, and First Coast — publish LCDs that list the covered CPT codes (typically from the vascular diagnostic studies range), the covered ICD-10 diagnosis codes that establish medical necessity, and any frequency or documentation requirements.
Commonly Used Code Categories (Verify With Your MAC)
Noninvasive carotid function testing billing typically involves CPT codes from the non-invasive vascular diagnostic studies section. These generally include duplex scanning codes for extracranial arteries and unilateral or bilateral carotid studies. Your MAC's LCD will confirm which specific codes carry covered status and which require additional documentation or are excluded.
Do not add codes to your charge capture based on this article alone. The policy data does not list codes, and this post cannot substitute for your MAC's current LCD. Use the policy modification as a prompt to review and confirm — not as a code reference.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.